|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Scottish Agricultural College,3 Craibstone Estate, Bucksburn, Aberdeen AB21 9YA, United Kingdom
University of Nottingham,4 Sutton Bonington Campus, Loughborough LE12 5RD, United Kingdom
| ABSTRACT |
|---|
|
|
|---|
embryo, in vitro fertilization, insulin, leptin, oocyte development
| INTRODUCTION |
|---|
|
|
|---|
The primary objective of the present study was to assess the combined effects of body condition and level of feeding on the postfertilization developmental potential of oocytes recovered from heifers using ultrasound-guided transvaginal follicular aspiration (ovum pickup [OPU]). A secondary objective was to relate oocyte quality to the metabolic status of these animals, specifically to plasma concentrations of insulin, IGF1, and leptin. Finally, by collecting oocytes from repeated sessions of OPU (at two defined time points within each of three estrous cycles), it was possible to determine the effects of changes in nutritional status (i.e., the combined effects of level of feeding and changes in body composition and metabolism) over this period (lasting several weeks) on oocyte quality.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Animals and Experimental Design
Twenty-four beef x dairy heifers (Scottish Agricultural College) approximately 20 mo of age and with an average initial weight (mean ± SEM) of 432.7 ± 14.6 kg were used. All animals were accommodated in individual pens on slatted floors. Four months before the start of the experiment, the live weight and body condition score (BCS) of each heifer was recorded. Body condition was scored on the six-point scale of Lowman et al. [8], where 0 = lean and 5 = obese. To create homogeneous groups of animals of both low and moderate BCS at the beginning of the experimental period, heifers were allocated to one of several levels of feeding based on Agricultural and Food Research Council [9] values for the energy requirements of cattle. Once this had been achieved, animals were allocated at random within each of the two groups (low and moderate BCS) to one of two levels of feeding, either 500 kJ (maintenance [M]) or 1000 kJ of metabolizable energy per kilogram of metabolic live weight per day (twice maintenance [2M]), resulting in a 2 x 2 factorial design in which the factors were low versus moderate BCS and M versus 2M level of feeding. The diets were offered as two meals (at 0800 and 1600 h) daily. Details of diet composition and chemical analysis are presented in Table 1. The experiment was conducted over three successive estrous cycles and repeated 2 mo later (denoted as periods 1 and 2). To reduce excessive gain or loss of live weight throughout the study, animals were realigned to the same levels of BCS between the end of the first and the beginning of the second periods of study. Furthermore, the levels of feeding (M or 2M) for animals within each BCS group during period 2 were switched from that offered in period 1 so that animals fed at the M level during period 1 were fed at the 2M level during period 2, and vice versa.
|
Estrous Synchronization, Oocyte Recovery, and Follicular Growth
To establish a reference estrus at the beginning of each period, heifers were synchronized using a 10-day, progesterone-releasing, controlled internal drug-release dispenser (CIDR; SmithKline Beecham, Tadworth, Surrey, UK) containing 1.9 g of progesterone. A prostaglandin F2
analog (Luprositol 15 mg; Prosolvin, Intervet, Cambridge, UK) was administered i.m. 8 days after CIDR insertion. Heifers were predicted to be in estrus 2 days after CIDR removal (Day 0 = day of reference estrus) (Fig. 1).
|
Animals were subjected to ultrasound-guided transvaginal follicular aspiration (i.e., OPU) as described by Goodhand et al. [10], on Days 5 and 12 of each of the three successive estrous cycles within each of the two periods (Fig. 1). Briefly, at the beginning of each OPU session, heifers were sedated with 28 mg of xylazine hydrochloride (Rompun; Bayer AG, Leverkusen) administered i.m. before epidural anesthesia with 5 ml of lignocaine hydrochloride (Locovetic; Bimeda, UK) between the first and second coccygeal vertebrae. A 5-MHz curvilinear transducer (Aloka SSD-500 V; BCF Technology Ltd., Livingstone, UK) was inserted vaginally, and all visible follicles greater than 2 mm were aspirated using a single-lumen needle (20 gauge) at a vacuum pressure of 70 mm Hg into conical tubes containing 5 ml of warm PBS supplemented with 0.1% (w/v) BSA fraction V, 50 IU/ml of heparin, and antibiotics (50 IU/ml of penicillin, 50 µg/ml of streptomycin sulfate, and 100 µg/ml of neomycin).
Ovarian follicular growth was monitored daily for a 6-day period commencing 3 days after the second OPU session leading up to estrus within each estrous cycle (Fig. 1). Ovarian follicles were visualized by transrectal real-time ultrasonography using a 5-MHz transducer (Aloka SSD-500 V). The total number of visible (
2 mm) follicles and their diameters were recorded. Each day before the early morning meal during the period leading up to estrus within each cycle, blood samples were collected by jugular venipuncture into lithium-heparin tubes on ice. Additional blood samples were similarly collected on the day before, the day of, and the day after each session of OPU. Plasma harvested from these samples was stored at 20°C until analysis.
In Vitro Embryo Production
All reagents and media used in the present experiment were obtained from Sigma Chemical Co. (Dorset, UK) unless otherwise stated. Animal identity was retained throughout. Tubes containing aspirants were transported in a polystyrene box (at 37°C) to the laboratory, where the aspirants were filtered through sterile, 70-µm nylon gauze (BD Falcon, BD Biosciences, Oxford, UK) into PBS supplemented with 0.2% (w/v) BSA fraction V and antibiotics (50 IU/ml of penicillin, 50 µg/ml of streptomycin sulfate, and 100 µg/ml of neomycin), and cumulus-oocyte complexes (COCs) were graded according to the number of compact cumulus cell layers and granulation of the oocyte cytoplasm as described previously [10]. Only grade-1 through grade-3 COCs were selected for maturation. Selected COCs were washed twice in maturation medium (bicarbonate-buffered TCM199 with Earle salts supplemented with 0.4% [w/v] BSA fraction V, 10 µg/ml of FSH, 10 µg/ml of LH, and antibiotics [50 IU/ml of penicillin and 50 µg/ml of streptomycin sulfate]) and transferred into 50-µl drops of the same medium with granulosa cell monolayers (
20 oocytes/drop) overlaid with mineral oil. The granulosa cell monolayers were prepared from a single batch of frozen-thawed granulosa cells used throughout the experiment that were cultured for 4 days before each OPU session, with half the medium being renewed every 48 h. Oocytes were matured for 24 h at 38.8°C in a humidified atmosphere of 5% CO2 in air.
Frozen semen from a single bull was thawed at 35°C and layered (85 µl) under 1 ml of a modified calcium-free Tyrode albumin lactate pyruvate medium (TALP; capacitation medium; 0.6% [w/v] BSA fraction V, 50 IU/ ml of penicillin, and 50 µg/ml of streptomycin sulfate; pH 7.4) in conical tubes for a swimup procedure [11]. The upper 0.7 ml of medium was then collected after incubation for 0.5 h at 38.8°C. The pooled medium containing spermatozoa was centrifuged (300 x g) for 10 min, and the supernatant was removed, leaving the pellet in approximately 200 µl of capacitation medium. The pellet was resuspended, and motile spermatozoa were counted and added in a maximum of 4 µl of capacitation media to a 46-µl drop of fertilization media to give a final concentration of 1 x 106 motile spermatozoa/ml. Fertilization medium was a modified TALP [12] supplemented with 0.2 nmol/ml of penicillamine, 0.1 nmol/ml of hypotaurine, 0.02 nmol/ml of epinephrine, 0.6% (w/v) BSA (fatty acid-free), 30 µg/ml of heparin, 50 IU/ml of penicillin, and 50 µg/ml of streptomycin sulfate (pH 7.8). Following maturation, most of the cumulus cells were removed by gentle pipetting, and oocytes were washed twice in Hepes-buffered TALP supplemented with 0.3% (w/v) BSA fraction V, 50 IU/ml of penicillin, and 50 µg/ml of streptomycin sulfate. Matured oocytes were placed in a 46-µl drop of fertilization media. The oocytes and spermatozoa were incubated in 50-µl drops under mineral oil (up to 20 ova/drop) for 22 h at 38.8°C in a humidified atmosphere of 5% CO2 in air.
Following in vitro insemination, putative zygotes were removed and washed twice in synthetic oviduct fluid medium [13] containing 25 µmol/ ml of NaHCO3, 108 µmol/ml of NaCl, 7.2 µmol/ml of KCl, 1.7 µmol/ml of CaCl2, 1.2 µmol/ml of KH2PO4, 0.5 µmol/ml of MgCl2, 1.5 µmol/ml of glucose, 3.3 µmol/ml of sodium pyruvate, 33 µmol/ml of sodium lactate, 1 µmol/ml of L-glutamine, 50 IU/ml of penicillin, and 50 µg/ml of streptomycin sulfate supplemented with 0.3% (w/v) BSA fatty acid-free, 1% (v/v) nonessential amino acids, and 2% (v/v) essential amino acids. Groups of up to 20 putative zygotes were then placed in 20-µl microdrops of the culture medium in a humidified atmosphere of 5% CO2, 5% O2, and 90% N2 at 38.8°C, and droplets were renewed every 48 h. On Day 2 of development (Day 0 = day of in vitro fertilization), the cleavage rate was recorded, and cleaved zygotes were then cultured in 20-µl microdrops until Day 8. On Day 8, blastocyst yield, blastocyst quality [14], and blastocyst developmental stage were recorded. Day-8 blastocysts were then fixed individually in 1 ml of 3:1 acetic acid:ethanol solution per well in 24-well plates, stained with 10 µg/ml of Hoechst 33342 solution, and immediately visualized by fluorescence microscopy. Total cell number per blastocyst was recorded.
Glucose Tolerance and Insulin Resistance
An assessment of glucose tolerance was conducted during an induced estrus within 3 wk of the end of period 2. Estrus was induced on Day 12 of the estrous cycle following i.m. administration of Luprositol (15 mg) on Day 9. On the day before the glucose tolerance test, flexible catheters (18 gauge) were placed into the jugular vein of each heifer. The glucose tolerance test commenced 5 h after the animal's morning meal with an i.v. infusion of sterile glucose solution (Glucose 40% [w/v]; Arnolds Veterinary Products Ltd., Shrewsbury, UK) at 0.3 g/kg. Three blood samples, collected at 20-min intervals before glucose infusion, established glucose and insulin baselines. Glucose infusion was completed within 5 min, and this was followed by the collection of further blood samples at 5, 10, 20, 30, 40, 60, 80, 100, and 120 min postinfusion. All blood samples were collected into heparinized vacuum tubes and stored on ice until centrifugation (15 min at 600 x g). Plasma was transferred into cuvettes and stored at 20°C until analysis. Plasma samples were analyzed for glucose using a BMD/Hitachi 705 autoanalyzer. The kit for glucose was supplied by Randox Laboratories Ltd. (Glucose GOD PAP; catalog no. GL2623).
Hormone analysis
Plasma insulin concentrations were determined using a 125I-labeled insulin double-antibody RIA based on the method of Starr et al. [15]. The assay was modified to use porcine insulin (I-3505; 24 IU/mg) obtained from Sigma Co. Ltd. (UK) and guinea pig anti-porcine insulin, normal guinea pig serum, and sheep anti-guinea pig immunoglobulin G obtained as a gift from the Scottish Antibody Production Unit, Law Hospital (Carluke, Lanarkshire, Scotland). The [125I]porcine insulin solution was prepared using the chloramine T method [16]. The minimum detection limit of the assay (defined at the 85% effective dose) was 2.6 µIU/ml. The interassay coefficients of variation for low, medium ,and high controls were 8.2%, 9.0%, and 10.0%, respectively, and the corresponding intra-assay coefficients of variation were 6.7%, 7.9%, and 7.1%, respectively.
Plasma IGF1 concentrations were determined using a [125I]IGF1 double-antibody RIA based on the method of Armstrong et al. [17]. Plasma IGF1 was first separated from its binding proteins by acid-gel high-performance liquid chromatography according to the method of Owens et al. [18]. The RIA used recombinant human IGF1 and anti-human IGF1 polyclonal antiserum (rabbit), both obtained from GroPep Ltd. (Adelaide, Australia); normal rabbit serum; and donkey anti-rabbit immunoglobulin G obtained from Diagnostics Scotland (Law Hospital, Carluke, Scotland). The [125I]IGF1 solution was prepared using the chloramine T method [16]. All samples analyzed for IGF1 concentrations were processed in a single assay with a detection limit of 12.5 ng/ml and in which the coefficients of variation for low- and high-quality controls were 11.7% and 8.4%, respectively.
Plasma leptin concentrations were determined in duplicate using the method of Blache et al. [19]. The primary antibody, normal emu serum, and sheep anti-emu serum were both provided by Dr. Blache (University of Western Australia, Perth, Australia). Ovine leptin (supplied by Dr. Keisler, University of Missouri, Columbia, MO) was iodinated in-house as described above. The detection limit for leptin was 0.2 ng/ml, and the interassay coefficients of variation for low, medium, and high controls were 13.0%, 9.7%, and 10.5%, respectively. The corresponding intra-assay coefficients of variation were 12.8%, 9.9%, and 10.3%, respectively.
Data analysis
Changes in animal live weight, body condition, and plasma hormone concentrations during the three successive estrous cycles were analyzed by repeated-measures ANOVA within GenStat 6 [20], in which the main effects of body condition (low vs. moderate), level of feeding (M vs. 2M), period (1 vs. 2), week within period (OPU sessions 16), and all interactions were tested. Residual variation was partitioned into between-animal variation, period-within-animal variation, and week-within-period variation. The within-animal degrees of freedom were adjusted using the calculated Greenhouse-Geiser
to account for nonindependence of measurements between weeks in the same animal. The growth rate of the largest follicle during each of the six estrous cycles was calculated for each animal by regressing follicle diameter against day and then analyzing the regression coefficients by ANOVA. Data represent the predicted means with either appropriate standard error of difference (SED) or SEM.
Oocyte recovery and in vitro embryo production data (i.e., oocytes cleaved and Day-8 blastocyst yields) were analyzed using generalized linear models assuming binomial errors with logit link functions within the same statistical package. Terms fitted to the model were animal, period, body condition, level of feeding, and OPU session within period. Comparisons between means were conducted by analysis of deviance. Data are presented as predicted means from these models. Changes in blastocyst yields during the 7-wk experimental period (i.e., for Weeks 1, 2, 4, 5, 7, and 8 during which OPU was conducted) are presented as the change in logit proportions, with time (t) expressed as weeks.
Glucose tolerance was calculated according to the method described by Opsomer et al. [21] and was determined as fractional glucose turnover rate (k) and the half-life (T
) starting at 5 min after the infusion (T5). The k value represents the clearance of infused glucose and was calculated as
![]() |
is the time required for the glucose concentration to fall by half. Using this k value, the glucose T
was calculated as
![]() |
Max (insulin peak level insulin basal level). All parameters of the glucose tolerance test were tested for normality using the Ryan-Joiner test statistic and then analyzed by ANOVA. | RESULTS |
|---|
|
|
|---|
Mean live weight and BCS were lower (P < 0.001) at the beginning of each of the two experimental periods for heifers allocated to the low compared to those in the moderate BCS groups (Table 2). As anticipated, during the experimental period, animals fed at the M level retained their live weight and BCS. In contrast, for heifers fed at the 2M level, live weight and BCS increased (P < 0.001) (Table 2). The pattern and extent of the increases in live weight and BCS were the same for both periods of study.
|
Metabolic Hormones
Both moderate BCS and the 2M level of feeding increased (P < 0.001) plasma insulin concentrations compared to low BCS and the M level of feeding (Table 2). Mean plasma insulin concentrations did not differ between cycles but increased (P < 0.001) during the days leading up to estrus in each cycle (mean values of 21.0, 26.9, and 28.4 µIU/ml for the 2 days preceding and the day of estrus, respectively; SED = 1.50).
Mean plasma IGF1 concentrations increased (P < 0.01) with successive estrous cycles (230.4, 246.2, and 249.8 ng/ ml; SED = 6.34) and were greater (P < 0.05) for heifers with moderate compared to low BCS (Table 2). However, mean IGF1 concentrations were unaffected by the level of feeding. As with insulin, plasma concentrations of IGF1 peaked (P < 0.001) on the day of estrus (mean values of 227.5, 242.9, and 255.9 ng/ml for the 2 days preceding and the day of estrus, respectively; SED = 4.23). An interaction (P < 0.01) was observed between BCS, level of feeding, and day of cycle on plasma IGF1 concentrations, which indicated that the increase in plasma IGF1 concentrations in the days leading up to estrus was greatest in low-BCS heifers fed at the 2M level (207.3, 226.9, and 253.9 ng/ml; SED = 12.68).
Mean plasma leptin concentrations were greater (P < 0.001) for animals of moderate compared to low BCS and for animals fed at the 2M compared to the M level (Table 2). The interaction (P < 0.05) between BCS and level of feeding indicated that mean plasma leptin concentrations did not differ significantly between levels of feeding for animals of low BCS but did differ between levels of feeding for animals of moderate BCS. Mean plasma leptin concentrations increased (P < 0.001) with time (cycle number) on experiment (3.8, 4.0, and 4.3 ng/ml for cycles 1, 2, and 3, respectively; SED = 0.09), and an interaction (P < 0.001) was observed between level of feeding and cycle number, indicating that plasma leptin concentrations increased with time for heifers on the 2M (4.5, 4.9, and 5.4 ng/ml; SED = 0.25) but not for heifers on the M (3.1, 3.0, and 3.2 ng/ml; SED = 0.25) diets. In contrast to insulin and IGF1, plasma leptin concentrations did not vary over the 6-day period leading up to estrus in any of the three cycles averaged over both periods.
Glucose Tolerance Test
Baseline glucose concentrations were greater (P < 0.01) for heifers fed at the 2M compared to the M level but did not differ between BCS groups (Table 3). Peak concentrations of glucose following glucose infusion were greater (P < 0.05) for heifers of moderate compared to low BCS, and peak concentrations also were greater (P < 0.06) for heifers fed at the M compared to the 2M level. Glucose clearance rate (k) was greater (P < 0.05), and the half-life (T
) was lower (P < 0.05), for animals of moderate compared to low BCS.
|
Before glucose infusion, baseline insulin concentrations were greater (P < 0.01) for animals fed at the 2M compared to the M level, and baseline insulin concentrations were greater (P < 0.06) for animals in moderate compared to low BCS (Table 3). However, mean treatment differences in peak insulin concentrations and the increase in insulin concentration (
Max) following glucose infusion were not significantly different, although they were greater (P < 0.05) for heifers in the moderate-BCS/2M group than for those in the low-BCS/M group.
Follicular Growth
The total number of visible follicles per animal averaged 12.8 ± 0.23 and did not differ between treatments (Table 4). However, the number of large (>8 mm) follicles was greater (P < 0.01) for animals fed at the 2M compared to the M level. Similarly, the number of medium-sized (48 mm) follicles was greater (P < 0.01) for animals fed at the 2M compared to the M level. The number of small (<4 mm) follicles averaged 7.6 ± 0.23 and was unaffected by treatments. The growth rate and maximum diameter of the dominant follicle, as monitored over the 6-day period before estrus in each cycle, were greater for heifers fed at the 2M than at the M level.
|
Oocyte and Embryo Development In Vitro
The number of follicles observed before OPU averaged 11.9 ± 0.24 per animal and did not vary between treatments. The mean recovery rate (percentage of oocytes recovered per follicle aspirated) throughout the experimental period averaged 53.6% ± 1.16%, and an average of 5.8 ± 0.21 oocytes were recovered per animal. Of these, 5.3 ± 0.19 oocytes per animal were selected for maturation. None of these parameters was affected by the experimental treatments.
Cleavage rates averaged 58.1% ± 1.76%, and these also did not differ significantly between treatments. An interaction (P < 0.05) was observed, however, between BCS and level of feeding on mean blastocyst yield (Day-8 blastocysts of oocytes cleaved), indicating that blastocyst yields were lower for the two extreme nutritional combinations (i.e., low-BCS/M vs. moderate-BCS/2M) (Fig. 2a). An interaction (P < 0.05) also was observed between BCS, level of feeding, and OPU session, which indicated that as the six sessions of OPU (averaged over both periods) progressed, blastocyst yields decreased for heifers of moderate BCS fed at the 2M level relative to heifers of low BCS fed at the 2M level (Fig. 2b). Total cell number per Day-8 blastocyst did not differ significantly between treatments (mean ± SEM, 105.3 ± 3.85).
|
Metabolic Hormones and Oocyte Quality
Plasma insulin concentrations across treatments were positively correlated with both BCS (r = 0.63, P < 0.01) and plasma leptin concentrations (r = 0.71, P < 0.001). Plasma leptin concentrations also were positively correlated (r = 0.72, P < 0.001) with BCS, as were plasma IGF1 concentrations (r = 0.42, P < 0.05). As a consequence of these relationships, and because of the positive effects of feeding level on both plasma insulin and leptin concentrations (Table 2), none of these terms (i.e., insulin, IGF1, and leptin) had any additional effect, nor did they reduce the error terms substantially when fitted to multiple-regression models of cleavage rate and blastocyst yield that included animal BCS and feeding level as factors.
To assess the effects of high concentrations of plasma insulin and leptin on oocyte quality, a similar regression approach was initially applied to a restricted data set that included all animals within the moderate-BCS/2M group (n = 12). This analysis indicated no effect of plasma leptin within this subgroup of animals on postfertilization development of oocytes. Similarly, no effect of insulin on cleavage rates was shown. However, a negative relationship was found between plasma insulin concentrations and blastocyst yield (regression coefficient = 0.035 ± 0.012, P < 0.05). Furthermore, an interaction (P < 0.01) was observed between plasma insulin concentrations and OPU session on blastocyst yield such that relative to the first OPU session, in which the regression coefficient for blastocyst yield against insulin was 0.024 ± 0.016, corresponding coefficients for OPU sessions 26 were 0.004 ± 0.028, 0.147 ± 0.070, 0.357 ± 0.165, 0.504 ± 0.117, and 0.710 ± 0.312, respectively. To confirm these observations, a hyperinsulinemic state was formally designated as fasting plasma insulin concentrations more than three standard deviations above the combined mean of animals in the low-BCS/2M and moderate-BCS/M groups; animals in these groups had moderate concentrations of plasma insulin (Table 2). This formal designation revealed that 8 of the 12 heifers in the moderate-BCS/2M group were hyperinsulinemic. Neither plasma IGF1 nor plasma leptin concentrations differed between the eight hyperinsulinemic and four "normal" animals within this treatment group (Table 5). However, the hyperinsulinemic animals had fewer follicles (particularly medium-sized follicles), produced significantly fewer oocytes, and had lower blastocyst yields following in vitro fertilization and embryo culture.
|
| DISCUSSION |
|---|
|
|
|---|
Endocrinology
The factorial nature of the present study was purposely designed to create three groups of animals with low (
10 µIU/ml), moderate (
20 µIU/ml), and high (
50 µIU/ml) mean basal plasma insulin concentrations (Table 2), which are representative of the broad range of concentrations encountered in practice, with the lower values representative of those recorded with lactating cattle (218 µIU/ml) [26, 27]. The greater fasting (48 µIU/ml) and nonfasting (55 µIU/ml) plasma insulin concentrations associated with the fatter and better-fed animals are indicative of increased peripheral insulin resistance [28]. However, such animals remained capable of adequately metabolizing an i.v. infusion of glucose (0.3 g/kg) by further increasing peripheral circulating concentrations of insulin (Table 3). Glucose infusion has previously led to peak plasma insulin concentrations of approximately 210 µIU/ml in obese, nonlactating sheep [28]; 200 µIU/ml in midlactation dairy cows [21]; and 200 µIU/ml in obese, maiden heifers [29]. These values are broadly in line with those for low-BCS/2M and moderate-BCS/M heifers in the present study. The more extreme insulin values observed for moderate-BCS/2M heifers in the present study (basal, 55 µIU/ml; post-glucose infusion, 367 µIU/ml) are greater than those reported previously for ruminants and more akin to the extreme values reported for women with polycystic ovarian syndrome (PCOS; fasting insulin, 4052 µIU/ml; peak insulin post-glucose infusion, 400650 µIU/ml) [30]. Indeed, at the time of the glucose tolerance test, one animal in the present study had basal insulin concentrations of approximately 100 µIU/ml and a peak post-glucose infusion insulin concentration of approximately 850 µIU/ml (Fig. 3). Closer inspection of the plasma insulin data over the 12 sessions of OPU for this group of animals identified several other single-sample occasions with basal (fasting) insulin concentrations as high as 111 µIU/ml.
|
Inevitably, the present experimental design also led to the creation of three groups of animals with low (
2 ng/ ml), moderate (
4 ng/ml), and high (
7 ng/ml) mean plasma leptin concentrations (Table 2); therefore, the effects of insulin and leptin on follicular growth and oocyte quality cannot be easily separated. As with the other mammalian species examined, plasma leptin concentrations in ruminants are related to body fatness and level of feeding [31]. This latter effect can be attributed, at least in part, to the combined actions of insulin on leptin gene expression [32] and insulin-stimulated glucose uptake by adipocytes [33]. Surprisingly, we detected only a very modest effect of BCS on plasma IGF1 concentrations in this study. We had previously observed, using the same assay, a significant effect of feeding level on plasma concentrations of this growth factor, paralleling that of insulin [7].
Ovarian Folliculogenesis
Working with a heifer genotype similar to that used in the present study, Gong et al. [34] reported a significant increase in the number of small (24 mm) follicles, leading to an increase in the number of large (>9 mm) follicles following FSH treatment in heifers fed at the 2M compared to the M level. The population of medium-sized follicles was unaffected by the level of feeding in that study. Although broadly in agreement with the present results (Table 4), the apparent discrepancy with regard to the effects of diet on the number of follicles within each size category between studies may be caused by differences in the duration of exposure to the levels of feeding (3 wk in the study of Gong et al. [34] vs. a means of approximately 6, 9, and 12 wk in the present study). Similarly, Armstrong et al. [35] failed to observe any effect of feeding level (M vs. 2M) on granulosa cell proliferation in vitro, but the BCS of their animals was closer to that of the moderate-BCS group of heifers in the present study.
Body condition and level of feeding influence a number of factors that regulate ovarian follicular development, granulosa cell proliferation, and steroidogenesis. In this regard, the effects of insulin are particularly well documented. Insulin stimulates bovine granulosa [36] and thecal [37] cell proliferation, as well as steroidogenesis in vitro [38, 39]. Similarly, IGF1 stimulates granulosa cell proliferation and steroidogenesis in vitro [40, 41]. In contrast, leptin inhibits gonadotroph and/or insulin-induced steroidogenesis by granulosa and thecal cells in vitro, although it does not seem to be able to affect granulosa cell proliferation at physiological levels [42, 43]. The present study can shed no further light on these mechanisms, but it highlights the need to better understand the potentially interactive effects of BCS and level of feeding on granulosa cell proliferation and physiology.
Postfertilization Development
The highest blastocyst yields in the present study were for the treatment combinations low-BCS/2M and moderate-BCS/M (Fig. 2). These treatment combinations were associated with moderate concentrations of both plasma insulin and leptin (Table 2). It is tempting to speculate that moderate plasma concentrations of these two metabolic hormones are associated with improved postfertilization embryo development, whereas either low or high concentrations are associated with impaired postfertilization embryo development. This conclusion would certainly be consistent with the data of Armstrong et al. [7]. Regression analysis in which these two terms were fitted to a model that included BCS and feeding level as factors, however, indicated that neither plasma insulin nor plasma leptin could account for any substantial variation in postfertilization development that had not already been explained by these factors.
Hyperinsulinemia and Oocyte Quality
To our knowledge, this is the first report of hyperinsulinemia associated with impaired oocyte quality in ruminants. Indeed, hyperinsulinemia is poorly studied in ruminants, and little information is available concerning the effects of elevated plasma insulin concentrations on the postfertilization developmental potential of oocytes in cattle and sheep. Fasting plasma insulin concentrations for the eight hyperinsulinemic animals identified in the present study (58 µIU/ml) were greater than those previously reported for obese cattle and sheep (2433 µIU/ml) [28, 29] but comparable to the extreme values (4052 µIU/ml) reported in women with PCOS by Dunaif [30]. Indeed, in human subjects, the median (interquartile range) of serum insulin concentrations are 12 (1018) and 27 (1643) µIU/ml for normal and weight-matched anovulatory women with PCOS, respectively [44]. Large (1420 mm), persistent follicles were observed in four of the eight hyperinsulinemic animals on separate occasions following OPU during the six estrous cycles in the present study (data not shown). Large, persistent follicles yield developmentally less-competent oocytes [45], but because these follicles were not present at the time of follicular aspiration, this mechanism cannot explain the low blastocyst yields following OPU and in vitro fertilization in the present study. Instead, the data suggest that elevated concentrations of insulin in these animals may have had a more direct, negative impact on the follicle-enclosed oocyte, thus impairing postfertilization development. A causal mechanism for insulin is suggested, because the negative association of elevated plasma insulin concentrations with postfertilization development occurred in the absence of differences in circulating IGF1 and leptin (Table 5). This negative association also increased with time on experiment, suggesting that the cumulative effects of nutritional status reported in Figure 2 may result, at least in part, from the long-term, detrimental effects of high insulin concentrations on oocyte development. This raises the interesting, albeit speculative, idea that nutritional status and/or plasma insulin may exert greater effects on oocytes within preantral follicles. Alternatively, duration of exposure may be important.
Our laboratory has demonstrated previously that high-plane feeding, resulting in elevated plasma concentrations of both insulin and IGF1 in heifers, leads to impaired embryo development following in vitro maturation and fertilization of oocytes recovered from these animals [7]. These observations were associated with reduced steady-state concentrations of mRNA encoding IGF-binding protein-2 and -4 and the insulin receptor locally within small (<4 mm) antral follicles. Evidence suggests that expression of the IGF1 receptor also was reduced but did not reach statistical significance. Although it was hypothesized that the expected increase in the bioavailability of intrafollicular IGF1 and -2 may have been detrimental to the developing oocyte, the precise mechanisms of such an effect are not understood, and it is not known if similar effects were operating in the present study. However, peripheral concentrations of insulin for the eight hyperinsulinemic animals in the present study were significantly greater than those reported earlier. At present, the detrimental effects of hyperinsulinemia on the follicle-enclosed oocyte are not understood. However, Eppig et al. [46] showed that the coincubation of insulin (
126 mIU/ml) and FSH with murine oocyte-granulosa cell complexes derived from preantral follicles reduced the percentage of fertilized oocytes developing into blastocysts, and this observation is broadly in keeping with that reported here.
In conclusion, results from the present study show that the effects of level of feeding on oocyte quality are dependent on the body condition of the animal. High levels of feeding improve postfertilization development for animals in low body condition but reduce postfertilization development for animals in good body condition. Furthermore, the effects of high levels of feeding are cumulative, with blastocyst yields for heifers in moderately good body condition deteriorating over time relative to heifers in low body condition. The present study also shows, to our knowledge for the first time, evidence of impaired oocyte quality associated with hyperinsulinemia in ruminants. The data presented here establish a nutritional framework to enable quantifiable assessments of future dietary effects on oocyte quality in cattle, and they form the basis for further detailed studies into the underlying mechanisms of such effects.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Correspondence: Kevin Sinclair, School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK. FAX: 44 0 115 951 6060; kevin.sinclair{at}nottingham.ac.uk ![]()
Received: 4 March 2005.
First decision: 26 April 2005.
Accepted: 20 June 2005.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Louden, M. M Chi, and K. H Moley Crosstalk between the AMP-activated kinase and insulin signaling pathways rescues murine blastocyst cells from insulin resistance Reproduction, September 1, 2008; 136(3): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Watkins, A. Wilkins, C. Cunningham, V. H. Perry, M. J. Seet, C. Osmond, J. J. Eckert, C. Torrens, F. R. A. Cagampang, J. Cleal, et al. Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring J. Physiol., April 15, 2008; 586(8): 2231 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kadokawa, N. Tameoka, M. Uchiza, Y. Kimura, and M. Yonai Short Communication: A Field Study on the Relationship Between Body Condition and Embryo Production in Superovulated Holstein Yearling Heifers J Dairy Sci, March 1, 2008; 91(3): 1087 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Sinclair, C. Allegrucci, R. Singh, D. S. Gardner, S. Sebastian, J. Bispham, A. Thurston, J. F. Huntley, W. D. Rees, C. A. Maloney, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status PNAS, December 4, 2007; 104(49): 19351 - 19356. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Chagas, J. J. Bass, D. Blache, C. R. Burke, J. K. Kay, D. R. Lindsay, M. C. Lucy, G. B. Martin, S. Meier, F. M. Rhodes, et al. Invited Review: New Perspectives on the Roles of Nutrition and Metabolic Priorities in the Subfertility of High-Producing Dairy Cows J Dairy Sci, September 1, 2007; 90(9): 4022 - 4032. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wathes, D. R. E. Abayasekara, and R. J. Aitken Polyunsaturated Fatty Acids in Male and Female Reproduction Biol Reprod, August 1, 2007; 77(2): 190 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Fouladi-Nashta, C. G. Gutierrez, J. G. Gong, P. C. Garnsworthy, and R. Webb Impact of Dietary Fatty Acids on Oocyte Quality and Development in Lactating Dairy Cows Biol Reprod, July 1, 2007; 77(1): 9 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Freret, B Grimard, A A Ponter, C Joly, C Ponsart, and P Humblot Reduction of body-weight gain enhances in vitro embryo production in overfed superovulated dairy heifers. Reproduction, April 1, 2006; 131(4): 783 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J Adamiak, K Powell, J A Rooke, R Webb, and K D Sinclair Body composition, dietary carbohydrates and fatty acids determine post-fertilisation development of bovine oocytes in vitro Reproduction, February 1, 2006; 131(2): 247 - 258. [Abstract] [Full Text] [PDF] |
||||
| |||||||||